… effective treatment option for HER2-positive metastatic breast cancer,” they wrote, noting … (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world … the use of trastuzumab for HER2+ breast cancer and the potential impact of …

… of adult patients with HER2 positive (immunohistochemistry [IHC] … treatment of previously treated HER2 expressing tumours, including … )+) breast cancer who have received a prior anti-HER2-based … cancer medicines across multiple HER2 targetable cancers. Daiichi …

… the prevention of breast cancer recurrence in patients with HER2-positive (HER2+) breast cancer expressing the … HLA-A*02 genotype and HER2+ breast cancer who have completed treatment with …

… biopsy in metastatic breast cancer for identifying targetable … patients with metastatic HER2-positive breast cancer. It pairs … metastatic triple-negative breast cancer.[10] Most recently … with HER2-positive metastatic breast cancer progresses on standard HER2- …

… for women diagnosed with breast cancer, can often leave … positive, HER2-negative tumors and lymph node–negative breast cancer. This … patients with ER-positive breast cancer. Eligible patients can … K, DePolo J. Breast cancer survivorship screening and testing. …

… ;s potential to prevent breast cancer recurrence and transform patient … stage one to three, HER2-positive breast cancer. Researchers are combining the … experimental vaccine with standard chemotherapy and HER2 …

… hormone receptor-positive (HR+), HER2-negative (HER2-) early breast cancer, the 70-gene profiling … MammaPrint High Risk, HR+HER2- early [breast cancer] within a propensity score … chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world …

… GLSI-100 to prevent breast cancer recurrences, was announced … *02 genotype and HER2-positive breast cancer who have completed … 100 to prevent metastatic breast cancer recurrence in the … in patients with HER2-positive breast cancer following surgery, according …

… HLA-A*02-positive, HER2-positive breast cancer who have completed treatment … improve invasive breast cancer–free survival in patients with HER2-positive breast cancer following … HLA-A*02-positive, HER2-positive breast cancer with residual disease after …

… and everolimus in ER+/HER2- metastatic breast cancer, highlighting their clinical activity …